[1]
J. S. Mertens, “Use of Mycophenolate Mofetil in Patients with Severe Localized Scleroderma Resistant or Intolerant to Methotrexate”, Acta Derm Venereol, vol. 96, no. 4, pp. 510–513, Dec. 2015.